2007 International Peripheral Nerve Society Meeting at Snowbird, Utah

描述（由申请人提供）：2007年周围神经学会（PNS）会议将于2007年7月14日至18日在雪鸟犹他州举行。PNS是一个由医生和科学家组成的国际组织，致力于促进我们对周围神经生物学和疾病的理解，最终目的是为各种形式的周围神经疾病患者开发治疗方法。PNS促进基础和临床研究，医生和科学培训，以及临床护理标准的共识发展。PNS成员来自广泛的学术兴趣和部门。PNS在包括国际和多学科听众的两年期会议上追求其目标。会议的重点是将基础科学发现转化为患者的临床治疗。PNS为周围神经疾病的治疗制定了合作指南。下一代周围神经科学家和临床医生的发展和指导是PNS的重要作用，并鼓励初级成员出席，并促进与高级研究人员的互动。会议在非公开场合举行，以鼓励非正式的互动。会议结果发表在《外周神经系统杂志》上。周围神经疾病是一种常见的和重要的残疾原因。两年一度的外周神经学会会议汇集了来自世界各地的科学家和临床医生，以分享研究成果和开发新的治疗方法。会议通过传播重要的新思想（研究和治疗）和制定共识指南，直接影响公共卫生和患者护理。

DESCRIPTION (provided by applicant): The 2007 Peripheral Nerve Society (PNS) meeting will be held from July 14-18 2007 at Snowbird Utah. The PNS is an international organization of physicians and scientists dedicated to forwarding our understanding of peripheral nerve biology and disease, with the ultimate aim of developing treatments for patients with various forms of peripheral nerve disease. The PNS facilitates both basic and clinical research, physician and scientific training, and consensus development of clinical standards of care. PNS members come from a broad spectrum of academic interests and departments. The PNS pursues its goals at biennial meetings that include an international and multidisciplinary audience. The meetings focus on translating basic science discoveries into clinical treatments for patients. The PNS develops collaborative guidelines for treatment of peripheral nerve diseases. Development and mentorship of the next generation of peripheral nerve scientists and clinicians is an important role of the PNS, and junior member attendance is encouraged and interaction with senior investigators facilitated. Meetings are held in cloistered settings to encourage informal interactions. Meeting results are published in the Journal of the Peripheral Nervous System. Peripheral nerve diseases are a common and important cause of disability. The biennial Peripheral Nerve Society meeting brings together scientists and clinicians from across the world in order to share research findings and to develop new treatments. The meeting directly impacts public health and patient care by disseminating important new ideas (both research and therapeutic) and by developing consensus guidelines.